Manufacturer of Controlled Substances; Notice of Application, 81979 [2011-33421]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 250 / Thursday, December 29, 2011 / Notices
40 FR 43745–46, all applicants for
registration to import a basic class of
any controlled substance in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: December 22, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
States. The company is aware of the
requirement to obtain a DEA registration
as an exporter to conduct this activity.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than February 27, 2012.
Dated: December 20, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–33402 Filed 12–28–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
81979
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: December 20, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–33400 Filed 12–28–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[FR Doc. 2011–33421 Filed 12–28–11; 8:45 am]
Manufacturer of Controlled
Substances; Notice of Registration
Drug Enforcement Administration
BILLING CODE 4410–09–P
Manufacturer of Controlled
Substances; Notice of Application
DEPARTMENT OF JUSTICE
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on October 10, 2011,
Norac Inc., 405 S. Motor Avenue, Azusa,
California 91702–3232, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Drug
Schedule
wreier-aviles on DSK3TPTVN1PROD with NOTICES
Gamma
Hydroxybutyric
Acid
(2010).
Tetrahydrocannabinols (7370) .....
Methamphetamine (1105) ............
Pentobarbital (2270) .....................
Nabilone (7379) ............................
I
I
II
II
II
15:12 Dec 28, 2011
Jkt 226001
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated May 25, 2011, and
published in the Federal Register on
June 3, 2011, 76 FR 32225, AMPAC Fine
Chemicals LLC., Highway 50 and Hazel
Avenue Building 05011, Rancho
Cordova, California 95670, made
application to the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of the following basic
classes of controlled substances:
Drug
Schedule
Thebaine (9333) ...........................
Poppy Straw Concentrate (9670)
With regard to Gamma
Hydroxybutyric Acid (2010),
Tetrahydrocannabinols (7370), and
Methamphetamine (1105) only, the
company manufactures these controlled
substances in bulk solely for
distribution within the United States to
customers engaged in dosage-form
manufacturing.
With regard to Nabilone (7379), the
company presently manufactures a
small amount of this controlled
substance in bulk solely to conduct
manufacturing internal process
development. It is the company’s
intention that, when the manufacturing
process is refined to the point that its
Nabilone bulk product is available for
commercial use, the company will
export the controlled substance in bulk
solely to customers engaged in dosageform manufacturing outside the United
VerDate Mar<15>2010
Drug Enforcement Administration
II
II
The company is a contract
manufacturer. In reference to Poppy
Straw Concentrate the company will
manufacture Thebaine intermediates for
sale to its customers for further
manufacture. No other activity for this
drug code is authorized for registration.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
AMPAC Fine Chemicals LLC., to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated AMPAC Fine Chemicals
LLC., to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
By Notice dated September 9, 2011,
and published in the Federal Register
on September 15, 2011, 76 FR 57080,
Chemic Laboratories, Inc., 480 Neponset
Street, Building 7, Canton,
Massachusetts 02021, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of Cocaine (9041),
a basic class of controlled substance
listed in schedule II.
The company plans to manufacture
small quantities of the above listed
controlled substance for distribution to
its customers for the purpose of
research.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Chemic Laboratories, to manufacture the
listed basic class of controlled substance
is consistent with the public interest at
this time. DEA has investigated Chemic
Laboratories to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
E:\FR\FM\29DEN1.SGM
29DEN1
]]>Agencies
[Federal Register Volume 76, Number 250 (Thursday, December 29, 2011)]
[Notices]
[Page 81979]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-33421]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on October 10, 2011, Norac Inc.,
405 S. Motor Avenue, Azusa, California 91702-3232, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the following basic classes of controlled
substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)........... I
Tetrahydrocannabinols (7370)............... I
Methamphetamine (1105)..................... II
Pentobarbital (2270)....................... II
Nabilone (7379)............................ II
------------------------------------------------------------------------
With regard to Gamma Hydroxybutyric Acid (2010),
Tetrahydrocannabinols (7370), and Methamphetamine (1105) only, the
company manufactures these controlled substances in bulk solely for
distribution within the United States to customers engaged in dosage-
form manufacturing.
With regard to Nabilone (7379), the company presently manufactures
a small amount of this controlled substance in bulk solely to conduct
manufacturing internal process development. It is the company's
intention that, when the manufacturing process is refined to the point
that its Nabilone bulk product is available for commercial use, the
company will export the controlled substance in bulk solely to
customers engaged in dosage-form manufacturing outside the United
States. The company is aware of the requirement to obtain a DEA
registration as an exporter to conduct this activity.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than February 27, 2012.
Dated: December 20, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-33421 Filed 12-28-11; 8:45 am]
BILLING CODE 4410-09-P
